Here is a rundown of the ratings and target prices recommended by some of the world’s top brokerage firms on four prominent market stocks:

1. ICICI Lombard

  • Rating: Buy
  • Target Price: Rs 1550
  • Brokerage Firm: Motilal Oswal

Motilal Oswal, a leading domestic brokerage firm, has bestowed a ‘Buy’ rating on insurance sector company ICICI Lombard, setting a target price of Rs 1550. The firm believes ICICI Lombard is primed to grow with the evolving landscape of the insurance industry in India.

2. Mankind Pharma

  • Rating: Hold
  • Target Price: Rs 1830
  • Brokerage Firm: Jefferies

Global brokerage firm Jefferies has given a ‘Hold’ rating to Mankind Pharma, with a target price of Rs 1830. Jefferies views Mankind Pharma as a strong franchise and forecasts improved company performance in the near future.

Screenshot 2023 07 03 At 4.59.12 Pm Not Suzlon Only But Delhivery, Mankind, Icici Lombard Will Also Zoom To This Target

3. Delhivery

  • Rating: Outperform
  • Target Price: Rs 460
  • Brokerage Firm: Bernstein

Bernstein has assigned an ‘Outperform’ rating to New Age stock Delhivery, with a target price of Rs 460. Bernstein anticipates a surge in Delhivery’s performance due to improving cash flow and the company’s focus on cost reduction and revenue enhancement.

4. Suzlon

  • Rating: Buy
  • Target Price: Rs 22
  • Brokerage Firm: ICICI Securities

ICICI Securities, another top brokerage firm in the domestic market, has recommended a ‘Buy’ rating on Suzlon stock, with a target price of Rs 22. The firm opines that Suzlon is ahead in margins compared to market competitors and stands to benefit from the rapid advancements in renewable industries.

Providing most accurate Delhi NCR, National and Stock Market, Automobile stuffs since 2014. Experience in Journalism with 12 Years and Awarded by 4 Journalism HONORS in career. Putting best effort to provide most reliable news point.